Regeneron Pharmaceuticals (REGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2008 | 12-2007 | 12-2006 | 12-2005 | 12-2004 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 247,796 | 498,925 | 237,876 | 184,508 | 95,229 |
| Marketable Securities | 226,954 | 267,532 | 221,400 | 114,037 | 200,753 |
| Receivables | 35,212 | 18,320 | 7,493 | 36,521 | 43,102 |
| Inventories | N/A | N/A | N/A | 2,904 | 3,229 |
| TOTAL | $521,442 | $797,829 | $469,984 | $341,392 | $343,955 |
| Non-Current Assets | |||||
| PPE Net | 142,035 | 58,304 | 49,353 | 60,535 | 71,239 |
| Investments And Advances | 51,061 | 78,222 | 61,983 | 18,109 | 52,930 |
| Other Non-Current Assets | 9,682 | 1,903 | 3,770 | 3,465 | 4,984 |
| TOTAL | $202,778 | $138,429 | $115,106 | $82,109 | $129,153 |
| Total Assets | $724,220 | $936,258 | $585,090 | $423,501 | $473,108 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 36,168 | 39,232 | 21,471 | 23,337 | 18,872 |
| TOTAL | $83,672 | $283,664 | $45,014 | $40,357 | $34,139 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | 200,000 | 200,000 | 200,000 |
| Deferred Revenues | 47,504 | 44,432 | 23,543 | 17,020 | 15,267 |
| aiOther Non-Current Liabilities | 2,431 | 0 | 0 | 0 | 0 |
| TOTAL | $219,034 | $192,327 | $323,452 | $269,142 | $256,426 |
| Total Liabilities | $302,706 | $475,991 | $368,466 | $309,499 | $290,565 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 79,977 | 78,985 | 65,631 | 56,859 | 56,122 |
| Common Shares | 80 | 79 | 65 | 56 | 56 |
| Retained earnings | -873,265 | -793,217 | -687,617 | -585,280 | -489,834 |
| Other shareholders' equity | -114 | 170 | -231 | -785 | -3,068 |
| TOTAL | $421,514 | $460,267 | $216,624 | $114,002 | $182,543 |
| Total Liabilities And Equity | $724,220 | $936,258 | $585,090 | $423,501 | $473,108 |